Healthpeak Properties (NYSE:DOC) Stock Price Breaks Above Fifty Day Moving Average After Analyst Downgrade

Healthpeak Properties, Inc. (NYSE:DOC) shares passed above its fifty day moving average during trading on Wednesday after Barclays raised their price target on the stock from $23.00 to $24.00. The stock has a fifty day moving average of $19.79 and traded as high as $20.22. Barclays currently has an equal weight rating on the stock. Healthpeak Properties shares last traded at $20.1940, with a volume of 8,611,560 shares.

A number of other equities analysts have also weighed in on the stock. Scotiabank lifted their price target on shares of Healthpeak Properties from $19.00 to $21.00 and gave the company a “sector perform” rating in a report on Wednesday, May 27th. BMO Capital Markets increased their target price on Healthpeak Properties from $20.00 to $24.00 and gave the stock an “outperform” rating in a research report on Monday, June 15th. Raymond James Financial assumed coverage on Healthpeak Properties in a report on Wednesday, June 17th. They issued a “market perform” rating on the stock. Mizuho boosted their price target on Healthpeak Properties from $21.00 to $24.00 and gave the company an “outperform” rating in a research report on Monday, July 6th. Finally, Citigroup upped their price target on Healthpeak Properties from $20.00 to $22.00 and gave the stock a “neutral” rating in a research note on Tuesday, August 11th. Four investment analysts have rated the stock with a Buy rating and fourteen have issued a Hold rating to the stock. According to MarketBeat, the company has a consensus rating of “Hold” and an average price target of $21.47.

Healthpeak Properties News Roundup

Here are the key news stories impacting Healthpeak Properties this week:

• Positive Sentiment: Healthpeak raised its 2026 adjusted FFO guidance to $1.76–$1.78 per share, broadly in line with the $1.77 consensus. Management pointed to outpatient leasing and senior-housing growth, while Q3 revenue rose 16.3% year over year. Zacks article
• Positive Sentiment: Management described broad operating momentum and expects to lease up recently acquired lab properties over two to three years. A potential recovery in life-science real estate is also cited by analysts as a possible longer-term catalyst. Healthpeak guidance and lab lease-up
• Neutral Sentiment: Q3 results were mixed: adjusted FFO declined year over year, while revenue increased. Revenue also came in below one reported FactSet estimate, though it exceeded other estimates cited in coverage. Q3 results
• Negative Sentiment: Refinancing risk remains a concern, and Cantor Fitzgerald cut its price target from $23 to $21 while maintaining a neutral rating. The target reduction may limit enthusiasm despite the improved guidance. Refinancing risk coverage

Hedge Funds Weigh In On Healthpeak Properties

Several hedge funds and other institutional investors have recently made changes to their positions in DOC. VIRGINIA RETIREMENT SYSTEMS ET Al acquired a new stake in shares of Healthpeak Properties during the 2nd quarter valued at approximately $3,837,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its holdings in Healthpeak Properties by 20,832.8% in the second quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 6,217,474 shares of the real estate investment trust’s stock worth $133,054,000 after purchasing an additional 6,187,772 shares during the period. Concurrent Investment Advisors LLC boosted its holdings in Healthpeak Properties by 70.7% in the second quarter. Concurrent Investment Advisors LLC now owns 63,838 shares of the real estate investment trust’s stock worth $1,366,000 after purchasing an additional 26,447 shares during the period. NewEdge Advisors LLC boosted its holdings in Healthpeak Properties by 23.1% in the second quarter. NewEdge Advisors LLC now owns 146,336 shares of the real estate investment trust’s stock worth $3,132,000 after purchasing an additional 27,508 shares during the period. Finally, Envestnet Asset Management Inc. increased its stake in Healthpeak Properties by 83.4% during the second quarter. Envestnet Asset Management Inc. now owns 7,761,469 shares of the real estate investment trust’s stock valued at $166,095,000 after purchasing an additional 3,530,429 shares during the last quarter. Institutional investors and hedge funds own 93.57% of the company’s stock.

Healthpeak Properties Trading Up 3.2%

The company has a quick ratio of 3.02, a current ratio of 1.29 and a debt-to-equity ratio of 0.87. The firm’s 50 day simple moving average is $19.79 and its two-hundred day simple moving average is $19.17. The stock has a market cap of $13.92 billion, a P/E ratio of 37.40, a price-to-earnings-growth ratio of 2.41 and a beta of 1.01.

Healthpeak Properties (NYSE:DOC) last posted its quarterly earnings results on Monday, November 2nd. The real estate investment trust reported $0.02 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.43 by ($0.41). Healthpeak Properties had a return on equity of 4.04% and a net margin of 12.32%. The business had revenue of $820.89 million during the quarter, compared to the consensus estimate of $739.18 million. During the same quarter in the previous year, the business posted $0.46 earnings per share. The company’s quarterly revenue was up 16.3% compared to the same quarter last year. As a group, equities research analysts predict that Healthpeak Properties, Inc. will post 1.77 earnings per share for the current fiscal year.

Healthpeak Properties Dividend Announcement

The firm also recently announced a monthly dividend, which will be paid on Wednesday, December 30th. Shareholders of record on Friday, December 18th will be issued a $0.1017 dividend. The ex-dividend date of this dividend is Friday, December 18th. This represents a $1.22 dividend on an annualized basis and a yield of 6.0%. Healthpeak Properties’s dividend payout ratio (DPR) is currently 225.93%.

About Healthpeak Properties

Healthpeak Properties, Inc (NYSE:DOC) is a real estate investment trust that owns, operates and develops healthcare-related real estate in the United States. The company primarily serves healthcare providers, research organizations and senior-care operators through a portfolio of specialized properties.

Its main activities include the ownership and leasing of outpatient medical office buildings, life science facilities and senior housing properties. These assets support services such as physician practices, ambulatory care, medical research and senior living.